March 20, 2024

Zotefoams Plc CEO David Sterling discusses the company's impressive performance for 2023, highlighting innovative strides in cellular material technology and strategic partnerships with Nike...
Diversified Energy Company plc CEO and CFO discuss robust performance strategies, acquisitions, and sustainability efforts despite low gas prices. Exciting plans for 2024 and beyond...
Versarien plc raises £615,000 through a placing of 492,000,000 new ordinary shares. Funds to support turnaround strategy & pursue commercial opportunities...
Learn about KEFI Gold and Copper plc's upcoming presentation at the Swiss Mining Institute investment conference in Zurich on 20-21 March 2024...
XP Factory plc (LON:XPF) CEO Richard Harpham discusses the company's impressive interim results, highlighting revenue growth and expansion strategies with DirectorsTalk Interviews...
Computacenter plc announces impressive financial results for 2023, with growth in revenue, profit, and earnings per share. CEO Mike Norris highlights continued investment for future growth...
Johnson Matthey Plc (LON:JMAT) has signed an agreement to sell its Medical Device Components business to Montagu Private Equity for US$700 million (£550 million)...
Prudential plc (LON:PRU) announces strong financial results for 2023 with new business profit up 45%, operating free surplus generated at $2,740 million, and adjusted operating profit up 8%. CEO Anil Wadhwani highlights progress on strategic objectives...
Poolbeg Pharma plc has received a Notice of Allowance from the US Patent Office for its Immunomodulator II patent application, enhancing the value of its promising POLB 001 therapy for potential partners. CEO Jeremy Skillington highlights the potential of POLB 001 in breakthrough cancer immunotherapies...
Search

Funds

March 20, 2024

FTSE 100

Funds